UW-Madison researchers involved in two Madison-based stem cell companies have received a federal grant to test experimental therapies for heart failure in pigs.
The $765,000 grant, announced last week, will allow Dr. Amish Raval, co-founder of Cellular Logistics, and Dr. Tim Kamp, a founder of and consultant to Fujifilm Cellular Dynamics Inc., or FCDI, to test two related treatments on four groups of pigs after heart attacks.
More than 5 million Americans suffer from heart failure each year, according to the Centers for Disease Control and Prevention, typically after heart attacks damage heart muscle cells and impair the heart’s ability to pump blood. Read the full story here.
;
